CVS Health Corp (CVS.N)
65.12USD
20 Apr 2018
$-0.74 (-1.12%)
$65.86
$65.66
$66.29
$64.70
1,638,879
1,989,798
$84.00
$60.15
About
Overall
| Beta: | 0.90 |
| Market Cap(Mil.): | $78,194.16 |
| Shares Outstanding(Mil.): | 1,016.57 |
| Dividend: | 0.50 |
| Yield (%): | 2.60 |
Financials
| CVS.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 15.33 | 20.98 | 40.93 |
| EPS (TTM): | 5.02 | -- | -- |
| ROI: | 8.05 | 11.72 | 62.12 |
| ROE: | 15.36 | 13.91 | 73.69 |
BRIEF-CVS Health Appoints Kevin Hourican As President Of CVS Pharmacy
* CVS HEALTH APPOINTS KEVIN HOURICAN AS PRESIDENT OF CVS PHARMACY Source text for Eikon: Further company coverage:
BRIEF-Cvs Health Expands Safe Drug Disposal At CVS Pharmacy Locations In West Virginia To Help Combat Opioid Abuse
* CVS HEALTH EXPANDS SAFE DRUG DISPOSAL AT CVS PHARMACY LOCATIONS IN WEST VIRGINIA TO HELP COMBAT OPIOID ABUSE Source text for Eikon: Further company coverage:
CVS Health appoints Marc-David Munk as CMO of MinuteClinic
CVS Health on Friday named Marc-David Munk as the new chief medical officer of MinuteClinic, the drugstore chain's retail medical clinic unit and as associate chief medical officer of the company.
CVS Health appoints Marc-David Munk as CMO of MinuteClinic
April 13 CVS Health on Friday named Marc-David Munk as the new chief medical officer of MinuteClinic, the drugstore chain's retail medical clinic unit and as associate chief medical officer of the company.
BRIEF-CVS Health Names Marc David Munk As Associate Chief Medical Officer
* DAVID MUNK, MD, MPH, MHCM, AS CHIEF MEDICAL OFFICER OF MINUTECLINIC AND ASSOCIATE CHIEF MEDICAL OFFICER OF CVS HEALTH Source text for Eikon: Further company coverage:
BRIEF-CVS Health Corp Says CEO Larry Merlo's FY 2017 Total Compensation Was $12.3 Mln
* CVS HEALTH CORP SAYS CEO LARRY MERLO'S FY 2017 TOTAL COMPENSATION WAS $12.3 MLN VS $18.4 MLN IN FY 2016 - SEC FILING Source text: [https://bit.ly/2GSQkSd] Further company coverage:
CVS rolls out new tool to combat rising drug prices
Drugstore chain CVS Health Corp on Wednesday launched a new tool that will allow pharmacies help customers tackle the soaring cost of drugs by comparing prices of medicines.
CVS rolls out new tool to combat rising drug prices
April 11 Drugstore chain CVS Health Corp on Wednesday launched a new tool that will allow pharmacies help customers tackle the soaring cost of drugs by comparing prices of medicines.
BRIEF-CVS Health Announces Plans To Focus On Kidney Care And Dialysis Treatment
* ANNOUNCES PLANS TO FOCUS ON KIDNEY CARE AND DIALYSIS TREATMENT
FDA working on a 'dozen' policies to boost copycat biotech drugs
NEW YORK The U.S. Food & Drug Administration is working on around a dozen actions to boost use of cheaper versions of expensive biotech medicines, the head of the agency Scott Gottlieb said on Wednesday.
Competitors
| Price | Chg | |
|---|---|---|
| Catamaran Corp (CCT.TO) | -- | -- |
| Humana Inc (HUM.N) | $294.12 | -0.88 |
| Rite Aid Corporation (RAD.N) | $1.58 | -0.02 |
| Rite Aid Corporation (RADCP.PK) | -- | -- |
| Walmart Inc (WMT.N) | $86.98 | -0.91 |
Estimates